Search Within

Kevin Joseph Curran

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (16)
  3. Research Letter (1)
Groups
  1. Epidemiology and Biostatistics (37)
  2. Pediatrics, Department of (37)
  3. Stem Cell Transplantation and Cellular Therapy Service (37)
  4. Biostatistics Service (36)
  5. Department of Medicine (34)
  6. GSK Faculty (30)

More Groups

People
  1. Audrey Mauguen (23)
  2. Jaap Jan Boelens (23)
  3. Nancy Kernan (21)
  4. Richard O'Reilly (19)
  5. Andromachi Scaradavou (17)
  6. Farid Boulad (17)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (6)
  6. 2020 (6)

More Years

Publications
  1. Blood (9)
  2. Bone Marrow Transplantation (7)
  3. Blood Advances (4)
  4. Cytotherapy (4)
  5. Biology of Blood and Marrow Transplantation (2)
  6. Journal of Clinical Investigation (2)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Nature Publishing Group (8)
  3. Elsevier Inc. (4)
  4. Elsevier Science Ltd. (4)
  5. American Society for Clinical Investigation (2)
  6. Wiley Periodicals, Inc (2)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; Rivière, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia
    Journal Article

    Park, J. H.; Rivière, I.; Gonen, M.; Wang, X.; Sénéchal, B.; Curran, K. J.; Sauter, C.; Wang, Y.; Santomasso, B.; Mead, E.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • A Phase I trial of 19-28z CAR-T cells post-high dose therapy and autologous transplantation (HDT-ASCT) for relapsed and refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C.; Riviere, I.; Senechal, B.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Moskowitz, C.; Giralt, S.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling for improved diagnosis and therapy of pediatric acute leukemias
    Meeting Abstract

    Kobos, R.; He, J.; Steinherz, P. G.; Curran, K. J.; Renaud, T. M.; Forlenza, C.; Boulad, F.; Prockop, S.; Knapp, K. M.; Walsh, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save